BlackRock’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-76,827
| Closed | -$32.3K | – | 5587 |
|
|
2024
Q4 | $32.3K | Hold |
76,827
| – | – | ﹤0.01% | 5033 |
|
|
2024
Q3 | $151K | Sell |
76,827
-1,471
| -2% | -$5.58K | ﹤0.01% | 4586 |
|
|
2024
Q2 | $418K | Buy |
78,298
+41,337
| +112% | +$173K | ﹤0.01% | 4389 |
|
|
2024
Q1 | $111K | Hold |
36,961
| – | – | ﹤0.01% | 4703 |
|
|
2023
Q4 | $232K | Sell |
36,961
-2
| -0% | -$15 | ﹤0.01% | 4600 |
|
|
2023
Q3 | $817K | Buy |
36,963
+36,450
| +7,105% | +$951K | ﹤0.01% | 4297 |
|
|
2023
Q2 | $3.62K | Hold |
513
| – | – | ﹤0.01% | 5331 |
|
|
2023
Q1 | $23.6K | Hold |
513
| – | – | ﹤0.01% | 5233 |
|
|
2022
Q4 | $72.8K | Hold |
513
| – | – | ﹤0.01% | 5135 |
|
|
2022
Q3 | $290K | Hold |
513
| – | – | ﹤0.01% | 4879 |
|
|
2022
Q2 | $415K | Sell |
513
-70
| -12% | -$104K | ﹤0.01% | 4832 |
|
|
2022
Q1 | $1.53M | Buy |
583
+1
| +0.2% | +$2.12K | ﹤0.01% | 4504 |
|
|
2021
Q4 | $1.5M | Sell |
582
-6
| -1% | -$20.9K | ﹤0.01% | 4509 |
|
|
2021
Q3 | $2.69M | Sell |
588
-6
| -1% | -$30.2K | ﹤0.01% | 4191 |
|
|
2021
Q2 | $3.54M | Sell |
594
-7
| -1% | -$45.2K | ﹤0.01% | 4026 |
|
|
2021
Q1 | $4.87M | Buy |
601
+160
| +36% | +$1.69M | ﹤0.01% | 3952 |
|
|
2020
Q4 | $2.73M | Hold |
441
| – | – | ﹤0.01% | 3937 |
|
|
2020
Q3 | $3M | Buy |
441
+113
| +34% | +$838K | ﹤0.01% | 3778 |
|
|
2020
Q2 | $2.08M | Buy |
328
+122
| +59% | +$518K | ﹤0.01% | 3813 |
|
|
2020
Q1 | $668K | Hold |
206
| – | – | ﹤0.01% | 3989 |
|
|
2019
Q4 | $1.2M | Hold |
206
| – | – | ﹤0.01% | 3948 |
|
|
2019
Q3 | $2.57M | Hold |
206
| – | – | ﹤0.01% | 3669 |
|
|
2019
Q2 | $1.74M | Sell |
206
-290
| -58% | -$3.4M | ﹤0.01% | 3825 |
|
|
2019
Q1 | $6.52M | Buy |
496
+85
| +21% | +$1.45M | ﹤0.01% | 3317 |
|
|
2018
Q4 | $6.19M | Buy |
411
+24
| +6% | +$564K | ﹤0.01% | 3319 |
|
|
2018
Q3 | $14.4M | Buy |
387
+22
| +6% | +$725K | ﹤0.01% | 3045 |
|
|
2018
Q2 | $14.1M | Buy |
365
+333
| +1,041% | +$12.6M | ﹤0.01% | 3060 |
|
|
2018
Q1 | $1.04M | Buy |
32
+1
| +3% | +$26.9K | ﹤0.01% | 3869 |
|
|
2017
Q4 | $647K | Hold |
31
| – | – | ﹤0.01% | 4006 |
|
|
2017
Q3 | $647K | Hold |
31
| – | – | ﹤0.01% | 4012 |
|
|
2017
Q2 | $491K | Sell |
31
-117
| -79% | -$2.34M | ﹤0.01% | 4028 |
|
|
2017
Q1 | $3.9M | Buy |
+148
| New | +$4.16M | ﹤0.01% | 3459 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 3558 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 3488 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3471 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3426 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3339 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 3170 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 3193 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 3106 |
|
BlackRock's TTOO Position: Q1 2025 in Review
BlackRock sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 76,827 shares — an estimated $32.3K sold.
BlackRock first reported a position in TTOO in Q1 2017 and held it in 32 quarters. The position peaked at $14.4M in Q3 2018. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.
- BlackRock reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
- BlackRock sold 76,827 T2 Biosystems, Inc shares in Q1 2025, an estimated $32.3K.
- BlackRock first reported a position in T2 Biosystems, Inc in Q1 2017 and held it in 32 quarters.
- BlackRock's T2 Biosystems, Inc position peaked at $14.4M in Q3 2018.
- 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.
Based on BlackRock's 13F filing for Q1 2025, filed 2 May 2025.